The influence of sFlt-1 on VEGF signaling and the development of vascular dysfunction in preeclampsia has not been fully explored at a molecular level, despite its use as a routinary diagnostic biomarker in many countries including the United Kingdom. Here, VEGFA is linked to preeclampsia.